CapsoVision CV
NASDAQ CV
$6.33 -0.13 (-2.01%)
As of: Oct 1, 2026 · 11:48 AM EDT

CapsoVision (CV) Preferred Stock Liabilities (2024 - 2025)

Updated

CapsoVision's Preferred Stock Liabilities was $143.63 million in Q2 2025, up 11.7% from $128.63 million a year earlier.

Analysis

CapsoVision (CV) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

From Q2 2024 onward, CapsoVision has reported Preferred Stock Liabilities for 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 CapsoVision 323.21 Mn 323.21 Mn 1.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 143.63 Mn
Dec 31, 2024 143.63 Mn
Sep 30, 2024 138.63 Mn
Jun 30, 2024 128.63 Mn
API Access

CapsoVision Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CV&period=max&api_key=YOUR_API_KEY